Katz Barrett 4
4 · Viridian Therapeutics, Inc.\DE · Filed Jan 21, 2021
Insider Transaction Report
Form 4
Katz Barrett
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-01-18+356,000→ 356,000 totalExercise: $23.03Exp: 2031-01-17→ Common Stock (356,000 underlying)
Footnotes (1)
- [F1]The option vests 25% on January 18, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.